Along with numerous studies linking some TP53 missense mutations as carriers of gain-of-function oncogenic activities (GOFs) in sporadic (unfamiliar) kinds of cancer, genetic studies in LFS have suggested that inherited TP53 mutations may be responsible for the increased susceptibility to cancer [7,8,9]. The gene discussed is TP53; the disease is cancer.